The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

TAP Sleep Care ®, a leader in innovative oral appliance therapy for snoring and obstructive sleep apnea (OSA), today ...

Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related ...

Eli Lilly and Company (NYSE: LLY) today announced that basketball legend and cultural icon Shaquille O'Neal is sharing his personal experience with moderate obstructive sleep apnea (OSA), including ...

Adults with severe sleep apnea face roughly four to five times the odds of developing atrial fibrillation, the most common ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Please provide your email address to receive an email when new articles are posted on . Oxygen desaturation index was used as a marker of obstructive sleep apnea severity. The link between this marker ...

Moderate to severe obstructive sleep apnea (OSA) independently correlated with development of cerebral microbleeds seen on brain MRI. Cerebral microbleeds are considered an early marker of cerebral ...

Young children aged 0 to 2 years who were hospitalized due to severe lower respiratory tract infection had the highest risk for OSA. Infants with severe early‐life lower respiratory tract infections ...

Please provide your email address to receive an email when new articles are posted on . Living in a deprived vs. not deprived area did not significantly alter the risk for severe obstructive sleep ...

Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep apnea and increased risk of cerebral microbleeds. Cerebral microbleeds ...